Status:
TERMINATED
Use of Sucrose to Relieve Pain During Eye Exams in Infants
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Apnea of Prematurity
Retinopathy of Prematurity
Eligibility:
All Genders
5+ years
Phase:
NA
Brief Summary
The purpose of this study is to see if an oral sucrose solution can comfort premature infants during their necessary eye exams. The investigators believe that the use of this solution prior to the eye...
Eligibility Criteria
Inclusion
- All premature infants admitted to the Neonatal Intensive Care Unit requiring serial dilated examinations to assess for retinopathy of prematurity will be candidates for this study. This includes all infants with a birthweight of less than 1500 g and infants between 1500 g and 2000 g who require supplemental oxygen.
Exclusion
- Any infant who is unable to safely suckle 0.5 cc of fluid will be excluded from the study. This includes infants that are being maintained on ventilators and those with serious gastrointestinal complications that may be exacerbated by an oral fluid bolus.
- Any infant being maintained on narcotics for any reason will not be eligible for the study.
- All infants with major congenital anomalies will be excluded.
Key Trial Info
Start Date :
July 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT00161694
Start Date
July 1 2005
Last Update
June 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYPH - Weill Cornell Medical Center
New York, New York, United States, 10021